title: [Venous interventions--part 1: techniques and lower torso thromboses].
abstract: Venous thrombosis is one of the most common vascular diseases. Without treatment, pulmonary embolism is a potentially life-threatening complication. Long-term complications are chronic venous insufficiency and post-thrombotic syndrome. Medical anticoagulation is currently the standard therapy, since it prevents appositional thrombus growth although it usually can not prevent the development of post-thrombotic syndrome. The structure of the thrombotic material often leads to partial recanalisation with residual stenosis. Early and sufficient systemic thrombolysis with adequate concentration may achieve disintegration of the thrombus and preservation of venous valve function. Supplementary to conservative therapy, local catheter thrombolysis is possible even in cases with contraindications for a systemic thrombolysis therapy. Additional interventional techniques reduce the required concentration of the thrombolytic. Venous stenosis can be treated by balloon angioplasty and stent implantation. This article reviews the different percutaneous treatment options as well as their application and usefulness in thrombosis of the lower torso.
authors.affiliation: Klinik für diagnostische und interventionelle Radiologie, Helios Klinikum Wuppertal, Universitätsklinik Witten/Herdecke, Wuppertal, Deutschland. lars.kamper@helios-kliniken.de
authors.forename: L
authors.initials: L
authors.lastname: Kamper
authors.forename: K
authors.initials: K
authors.lastname: Krüger
authors.forename: A
authors.initials: A
authors.lastname: Altenburg
authors.forename: M
authors.initials: M
authors.lastname: Mansour
authors.forename: P
authors.initials: P
authors.lastname: Reimer
authors.forename: P
authors.initials: P
authors.lastname: Haage
mesh_terms: D000287:Administration, Topical; D000792:Angiography; D000800:Angioplasty, Balloon / Q000379:methods*; D005268:Femoral Vein / Q000000981:diagnostic imaging; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007084:Iliac Vein / Q000000981:diagnostic imaging; D007262:Infusions, Intravenous; D010690:Phlebography; D011655:Pulmonary Embolism / Q000000981:diagnostic imaging / Q000517:prevention & control / Q000628:therapy*; D015607:Stents; D017131:Thrombectomy; D015912:Thrombolytic Therapy / Q000009:adverse effects / Q000379:methods*; D014057:Tomography, X-Ray Computed; D016306:Vena Cava Filters; D014682:Vena Cava, Inferior / Q000000981:diagnostic imaging; D020246:Venous Thrombosis / Q000000981:diagnostic imaging / Q000628:therapy*
chemical_list: D005343:Fibrinolytic Agents